Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0IA7Z
|
|||
| Drug Name |
Carbamide derivative 1
|
|||
| Synonyms |
PMID26413912-Compound-49
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
JANSSEN PHARMACEUTICA NV KEITH, John, M. LIU, Jing
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H17ClF2N4O3
|
|||
| Canonical SMILES |
C1CN(CCN1CC2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4=C(C=CN=C4)Cl
|
|||
| InChI |
1S/C18H17ClF2N4O3/c19-13-3-4-22-10-14(13)23-17(26)25-7-5-24(6-8-25)11-12-1-2-15-16(9-12)28-18(20,21)27-15/h1-4,9-10H,5-8,11H2,(H,23,26)
|
|||
| InChIKey |
YWGYNGCRVZLMCS-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1346528-50-4
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| Fatty-acid amide hydrolase 1 (FAAH1) | Target Info | Inhibitor | [1] | |
| Target's Patent Info | Fatty acid amide hydrolase (FAAH) | Target's Patent Info | [1] | |
| Fatty-acid amide hydrolase 1 (FAAH1) | Target's Patent Info | [1] | ||
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Fatty acid amide hydrolase inhibitors: a patent review (2009-2014).Expert Opin Ther Pat. 2015;25(11):1247-66. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.